Journal of the American Medical Informatics Association, Vol 1, 404-411, Copyright © 1994 by American Medical Informatics Association

ARTICLES

Potential identifiability and preventability of adverse events using information systems

DW Bates, AC O'Neil, D Boyle, J Teich, GM Chertow, AL Komaroff and TA Brennan
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.

STUDY OBJECTIVE: To evaluate the potential ability of computerized information systems (ISs) to identify and prevent adverse events in medical patients. DESIGN: Clinical descriptions of all 133 adverse events identified through chart review for a cohort of 3,138 medical patients were evaluated by two reviewers. MEASUREMENTS: For each adverse event, three hierarchical levels of IS sophistication were considered: Level 1--demographics, results for all diagnostic tests, and current medications would be available on-line; Level 2--all orders would be entered on-line by physicians; and Level 3--additional clinical data, such as automated problem lists, would be available on- line. Potential for event identification and potential for event prevention were scored by each reviewer according to two distinct sets of event monitors. RESULTS: Of all the adverse events, 53% were judged identifiable using Level 1 information, 58% were judged identifiable using Level 2 information, and 89% were judged identifiable using Level 3 information. The highest-yield event monitors for identifying adverse events were "panic" laboratory results, unexpected transfer to an intensive care unit, and hospital-incurred trauma. With information from Levels 1, 2, and 3, 5%, 13%, and 23% of the adverse events, respectively, were judged preventable. For preventing these adverse events, guided-dose algorithms, drug-laboratory checks, and drug- patient characteristic checks held the most potential.

This article has been cited by other articles:

				E N de Vries, M A Ramrattan, S M Smorenburg, D J Gouma, and M A Boermeester The incidence and nature of in-hospital adverse events: a systematic review Qual. Saf. Health Care, June 1, 2008; 17(3): 216 - 223. [Abstract] [Full Text] [PDF]

				J. Ferranti, M. M. Horvath, H. Cozart, J. Whitehurst, and J. Eckstrand Reevaluating the Safety Profile of Pediatrics: A Comparison of Computerized Adverse Drug Event Surveillance and Voluntary Reporting in the Pediatric Environment Pediatrics, May 1, 2008; 121(5): e1201 - e1207. [Abstract] [Full Text] [PDF]

				J. M. Rothschild, F. A. Federico, T. K. Gandhi, R. Kaushal, D. H. Williams, and D. W. Bates Analysis of Medication-Related Malpractice Claims: Causes, Preventability, and Costs Arch Intern Med, November 25, 2002; 162(21): 2414 - 2420. [Abstract] [Full Text] [PDF]

				J. F. Peterson, D. H. Williams, A. Seger, T. K. Gandhi, and D. W. Bates Drug-Lab Triggers Have Potential to Prevent Adverse Drug Events in Outpatients J. Am. Med. Inform. Assoc., November 1, 2002; 9(90061): S39 - 40. [Full Text] [PDF]

				J. G. Anderson, S. J. Jay, M. Anderson, and T. J. Hunt Evaluating the Capability of Information Technology to Prevent Adverse Drug Events: A Computer Simulation Approach J. Am. Med. Inform. Assoc., September 1, 2002; 9(5): 479 - 490. [Abstract] [Full Text] [PDF]

				G. Neale, M. Woloshynowych, and C. Vincent Exploring the causes of adverse events in NHS hospital practice J R Soc Med, January 7, 2001; 94(7): 322 - 330. [Abstract] [Full Text] [PDF]

				I. S. Kohane Bioinformatics and Clinical Informatics: The Imperative to Collaborate J. Am. Med. Inform. Assoc., September 1, 2000; 7(5): 512 - 516. [Full Text]

				K. Walshe Adverse events in health care: issues in measurement Qual. Saf. Health Care, March 1, 2000; 9(1): 47 - 52. [Full Text]

				G. J. Kuperman, J. M. Teich, M. J. Tanasijevic, N. Ma'Luf, E. Rittenberg, A. Jha, J. Fiskio, J. Winkelman, and D. W. Bates Improving Response to Critical Laboratory Results with Automation: Results of a Randomized Controlled Trial J. Am. Med. Inform. Assoc., November 1, 1999; 6(6): 512 - 522. [Abstract] [Full Text] [PDF]

				S. H. Brown, R. A. Miller, H. N. Camp, D. A. Guise, and H. K. Walker Empirical Derivation of an Electronic Clinically Useful Problem Statement System Ann Intern Med, July 20, 1999; 131(2): 117 - 126. [Abstract] [Full Text] [PDF]

				D. W. Bates, J. M. Teich, J. Lee, D. Seger, G. J. Kuperman, N. Ma'Luf, D. Boyle, and L. Leape The Impact of Computerized Physician Order Entry on Medication Error Prevention J. Am. Med. Inform. Assoc., July 1, 1999; 6(4): 313 - 321. [Abstract] [Full Text] [PDF]

				D. W. Bates, L. L. Leape, D. J. Cullen, N. Laird, L. A. Petersen, J. M. Teich, E. Burdick, M. Hickey, S. Kleefield, B. Shea, et al. Effect of Computerized Physician Order Entry and a Team Intervention on Prevention of Serious Medication Errors JAMA, October 21, 1998; 280(15): 1311 - 1316. [Abstract] [Full Text] [PDF]

				D. W. Bates, S. J. Soldin, P. M. Rainey, and J. N. Micelli Strategies for physician education in therapeutic drug monitoring Clin. Chem., February 1, 1998; 44(2): 401 - 407. [Abstract] [Full Text] [PDF]

				G. J. Kuperman, D. Boyle, A. Jha, E. Rittenberg, N. Ma'Luf, M. J. Tanasijevic, J. M. Teich, J. Winkelman, and D. W. Bates How Promptly Are Inpatients Treated for Critical Laboratory Results? J. Am. Med. Inform. Assoc., January 1, 1998; 5(1): 112 - 119. [Abstract] [Full Text]